fluorodeoxyglucose f18 has been researched along with Adenoma, Hepatocellular in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Graham, RP; Kendi, AT; Venkatesh, SK; Young, JR | 1 |
Cherqui, D; Jarnagin, WR; Jessurun, J; Kingham, TP; Kluger, MD; LaGratta, MD; Lee, SY | 1 |
Fujii, T; Gabata, T; Harada, K; Matsui, O; Ozaki, K; Saitoh, S; Terayama, N; Tomimaru, Y | 1 |
Bernardi, M; Boschi, S; Colecchia, A; Fanti, S; Farsad, M; Feletti, V; Franchi, R; Frigerio, M; Golfieri, R; Jovine, E; Lodi, F; Magini, G; Patti, C; Serra, C; Trevisani, F; Vivarelli, M | 1 |
Klarhöfer, M; Lenz, C; Scheffler, K; Sommer, G; Winter, L | 1 |
Asakura, K; Kanemoto, H; Mizuno, T; Moriguchi, M; Sasaki, K; Sugiura, T; Sumiyoshi, T; Uesaka, K | 1 |
Böhm, B; Geoghegan, J; Gottschild, D; Hellfritzsch, H; Petrovich, A; Scheele, J; Voth, M | 1 |
2 review(s) available for fluorodeoxyglucose f18 and Adenoma, Hepatocellular
Article | Year |
---|---|
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies | 2021 |
Assessing extracranial tumors using diffusion-weighted whole-body MRI.
Topics: Adenoma, Liver Cell; Blood Glucose; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Lung Neoplasms; Male; Multiple Myeloma; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2011 |
5 other study(ies) available for fluorodeoxyglucose f18 and Adenoma, Hepatocellular
Article | Year |
---|---|
PET-avid hepatocellular adenomas: incidental findings associated with HNF1-α mutated lesions.
Topics: Adenoma, Liver Cell; Adult; Biomarkers, Tumor; Biopsy; Databases, Factual; Diagnostic Errors; DNA Mutational Analysis; False Positive Reactions; Female; Fluorodeoxyglucose F18; Hepatocyte Nuclear Factor 1-alpha; Humans; Incidental Findings; Liver Neoplasms; Male; Mutation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2016 |
Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomas exhibit high (18)F-fludeoxyglucose uptake associated with glucose-6-phosphate transporter inactivation.
Topics: Adenoma, Liver Cell; Adult; Antiporters; Female; Fluorodeoxyglucose F18; Hepatocyte Nuclear Factor 1-alpha; Humans; Liver Neoplasms; Middle Aged; Monosaccharide Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2016 |
C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma.
Topics: Acetates; Adenoma, Liver Cell; Adolescent; Adult; Aged; Aged, 80 and over; Carbon; Carbon Isotopes; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2009 |
Liver-specific contrast agent-enhanced magnetic resonance and ¹⁸F-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case.
Topics: Adenoma, Liver Cell; Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hepatectomy; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors.
Topics: Adenoma, Liver Cell; Breast Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver Neoplasms; Male; Neoplasm Staging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |